Page last updated: 2024-10-24

chloroquine and Alveolar Bone Atrophy

chloroquine has been researched along with Alveolar Bone Atrophy in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"Periodontitis is an inflammation characterized by alveolar bone resorption caused by imbalance in bone homeostasis."5.56Chloroquine and 3-Methyladenine Attenuates Periodontal Inflammation and Bone Loss in Experimental Periodontitis. ( Chen, B; He, S; Li, L; Luo, B; Yan, F; Zhou, Q, 2020)
"Periodontitis is an inflammation characterized by alveolar bone resorption caused by imbalance in bone homeostasis."1.56Chloroquine and 3-Methyladenine Attenuates Periodontal Inflammation and Bone Loss in Experimental Periodontitis. ( Chen, B; He, S; Li, L; Luo, B; Yan, F; Zhou, Q, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
He, S1
Zhou, Q1
Luo, B1
Chen, B1
Li, L1
Yan, F1

Other Studies

1 other study available for chloroquine and Alveolar Bone Atrophy

ArticleYear
Chloroquine and 3-Methyladenine Attenuates Periodontal Inflammation and Bone Loss in Experimental Periodontitis.
    Inflammation, 2020, Volume: 43, Issue:1

    Topics: Adenine; Alveolar Bone Loss; Alveolar Process; Animals; Anti-Inflammatory Agents; Autophagy; Autopha

2020